Survey of Ophthalmology
Volume 46, Issue 3 , Pages 209-233 , November 2001

Immunopathology of the Noninfectious Posterior and Intermediate Uveitides

  • Shelley Romayne Boyd, MD, FRCS(C)

      Affiliations

    • Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK
    • St Michael's Hospital, University of Toronto, Toronto, Canada
    • ,
  • Stephanie Young, FRACO, FRACS

      Affiliations

    • Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK
    • ,
  • Susan Lightman, PhD, FRCP, FRCOphth, F Med Sci

      Affiliations

    • Department of Clinical Ophthalmology, Institute of Ophthalmology, Moorfields Eye Hospital, London, UK
    • Corresponding Author InformationReprint address: Susan Lightman, PhD, FRCP, FRCOphth, Moorfields Eye Hospital, City Road, London, UK, EC1V 2PD

References 

  1. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet. 1990;335:1078–1080
  2. Alaez C, del Pilar Mora M, Arellanes L, et al.  Strong association of HLA class II sequences in Mexicans with Vogt– Koyanagi–Haradas disease. Hum Immunol. 1999;60:875–882
  3. Albert LJ, Inman RD. Molecular mimicry and autoimmunity. N Engl J Med. 1999;341:2068–2074
  4. Althaus C, Sundmacher R. Intermediate uveitis (epidemiology, age and sex distribution). Dev Ophthalmol. 1992;23:9–14
  5. Ando K, Fujino Y, Hijikata K, et al.  Epidemiological features and visual prognosis of Behçet's disease. Jpn J Ophthalmol. 1999;43:312–317
  6. Angi MR, Forattini F, Chilosi M, et al.  Immunopathology of ocular sarcoidosis. Int Ophthalmol. 1990;14:1–11
  7. Archambeau P, Hollenhorst RW, Rucker CW. Posterior uveitis as a manifestation of multiple sclerosis. Mayo Clin Proc. 1965;40:544–551
  8. Ariga H, Ohno S, Higuchi M, Matsuda H: [Immunological studies on lymphocytes in the cerebrospinal fluid of patients with Vogt–Koyanagi–Harada disease and sympathetic ophthalmia]. Nippon Ganka Gakkai Zasshi 92:225–8, 1988
  9. Arocker-Mettinger E, Georgiew L, Grabner G, Mayr WR. Intermediate uveitis (do HLA antigens play a role?). Dev Ophthalmol. 1992;23:15–19
  10. Arocker-Mettinger E, Mayr WR, Huber-Spitzy V, et al.  Do HLA antigens play a role in intermediate uveitis?. Vox Sang. 1992;63:282–284
  11. Aronson SB. Experimental allergic uveitis. Arch Ophthalmol. 1968;80:235–242
  12. Aronson SB. The homoimmune uveitises in the guinea pig. Ann NY Acad Sci. 1965;124:365–376
  13. Augsburger JJ, Annesley WH, Sergott RC, et al.  Familial pars planitis. Ann Ophthalmol. 1981;13:553–557
  14. Aydintug AO, Tokgoz G, DCruz DP, et al.  Antibodies to endothelial cells in patients with Behçet's disease. Clin Immunol Immunopathol. 1993;67:157–162
  15. Azar P, Gohd RS, Waltman D, Gitter KA. Acute posterior multifocal placoid pigment epitheliopathy associated with an adenovirus type 5 infection. Am J Ophthalmol. 1975;80:1003–1005
  16. Azen SP, Marak GE, Minckler DS, et al.  Histocompatibility antigens in sympathetic ophthalmia. Am J Ophthalmol. 1984;98:117–119
  17. Baarsma GS, Kijlstra A, Oosterhuis JA, et al.  Association of birdshot retinochoroidopathy and HLA-A29 antigen. Doc Ophthalmol. 1986;61:267–269
  18. Baglivo E, Rossillion B, De Gottrau P, Leuenberger P. Detection of anticytomegalovirus antibody synthesis in the anterior chamber in Vogt–Koyanagi–Harada syndrome. Br J Ophthalmol. 1998;82:1216–1217
  19. Balboni A, Pivetti-Pezzi P, Orlando P, et al.  Serological and molecular HLA typing in Italian Behçet's patients (significant association to B51-DR5-DQw3 haplotype). Tissue Antigens. 1992;39:141–143
  20. Bansal AS, Bruce J, Hogan PG, Allen RK. An assessment of peripheral immunity in patients with sarcoidosis using measurements of serum vitamin D3, cytokines and soluble CD23. Clin Exp Immunol. 1997;110:92–97
  21. Barnes CG, Yazici H. Behçet's syndrome. Rheumatology (Oxford). 1999;38:1171–1174
  22. Bec P, Arne JL, Philippot V: [Basal uveo-retinitis (peripheral uveitis, chronic posterior cyclitis, pars planitis, vitritis, hyalo-retinitis) and other inflammations of the peripheral retina]. Arch Ophtalmol (Paris) 37:169–96, 1977
  23. Becker MD, Rosenbaum JT. Current and future trends in the use of immunosuppressive agents in patients with uveitis. Curr Opin Ophthalmol. 2000;11:472–477
  24. Belfort R, Moura NC, Mendes NF. T and B lymphocytes in the aqueous humor of patients with uveitis. Arch Ophthalmol. 1982;100:465–467
  25. Ben-Chetrit E, Levy M. Colchicine (1998 update). Semin Arthritis Rheum. 1998;28:48–59
  26. BenEzra D: Histologic and immunopathologic findings in sympathetic ophthalmia. Arch Ophthalmol 103:625, 627, 1985
  27. Benezra D, Cohen E. Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol. 1986;70:589–592
  28. Benezra D, Maftzir G, Barak V. Blood serum interleukin-1 receptor antagonist in pars planitis and ocular Behçet disease. Am J Ophthalmol. 1997;123:593–598
  29. BenEzra D, Maftzir G, Kalichman I, Barak V. Serum levels of interleukin-2 receptor in ocular Behçet's disease. Am J Ophthalmol. 1993;115:26–30
  30. Berlin M, Fogdell-Hahn A, Olerup O, et al.  HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med. 1997;156:1601–1605
  31. Bhende PS, Biswas J, Madhavan HN. Serological evidence for active Epstein–Barr virus infection in multifocal choroiditis. Indian J Pathol Microbiol. 1997;40:129–131
  32. Bianco A, Spiteri MA. Peripheral anergy and local immune hyperactivation in sarcoidosis (a paradox or birds of a feather). Clin Exp Immunol. 1997;110:1–3
  33. Biousse V, Trichet C, Bloch-Michel E, Roullet E. Multiple sclerosis associated with uveitis in two large clinic-based series. Neurology. 1999;52:179–181
  34. Biswas J, Raghavendran SR, Vijaya R. Intermediate uveitis of pars planitis type in identical twins. Report of a case. Int Ophthalmol. 1998;22:275–277
  35. Bloch-Michel E, Campinchi R, Muller JY, et al.  HLA antigens and uveitis with special reference to Behçet's disease, chronic herpes simplex, toxoplasmosis, and recurrent acute anterior uveitis. In:  Silverstein AM,  OConnor GR editor. Immunology and immunopathology of the Eye. New York: Masson; 1979;p. 10–14
  36. Boisgerault F, Khalil I, Tieng V, et al.  Definition of the HLA-A29 peptide ligand motif allows prediction of potential T-cell epitopes from the retinal soluble antigen, a candidate autoantigen in birdshot retinopathy. Proc Natl Acad Sci USA. 1996;93:3466–3470
  37. Borruat FX, Herbort CP, Spertini F, Desarnaulds AB. HLA typing in patients with multiple evanescent white dot syndrome (MEWDS). Ocul Immunol Inflamm. 1998;6:39–41
  38. Braley RE, Meredith TA, Aaberg TM, et al.  The prevalence of HLA-B7 in presumed ocular histoplasmosis. Am J Ophthalmol. 1978;85:859–861
  39. Breeveld J, Rothova A, Kuiper H. Intermediate uveitis and Lyme borreliosis. Br J Ophthalmol. 1992;76:181–182
  40. Bresnitz EA, Strom BL. Epidemiology of sarcoidosis. Epidemiol Rev. 1983;5:124–156
  41. Callanan D, Gass JD. Multifocal choroiditis and choroidal neovascularization associated with the multiple evanescent white dot and acute idiopathic blind spot enlargement syndrome. Ophthalmology. 1992;99:1678–1685
  42. Capone A, Aaberg TM. Intermediate uveitis. In:  Albert D,  Jakobiec F editor. Principles & practice of ophthalmology. Philadelphia: WB Saunders and Co; 1996;p. 423–442
  43. Carney MD, Tessler HH, Peyman GA, et al.  Sympathetic ophthalmia and subretinal neovascularization. Ann Ophthalmol. 1990;22:184–186
  44. Cassoux N, Lehoang P: [Birdshot retinochoroidopathy]. Ann Med Interne (Paris) 151(Suppl 1):1S45–7, 2000
  45. Celenligil-Nazliel H, Kansu E, Ebersole JL. Periodontal findings and systemic antibody responses to oral microorganisms in Behçet's disease. J Periodontol. 1999;70:1449–1456
  46. Chan CC. Relationship between sympathetic ophthalmia, phacoanaphylatic endophthalmitis, and Vogt–Koyanagi–Harada disease. Ophthalmology. 1988;95:619–624
  47. Chan CC, BenEzra D, Hsu SM, et al.  Granulomas in sympathetic ophthalmia and sarcoidosis. Immunohistochemical study. Arch Ophthalmol. 1985;103:198–202
  48. Chan CC, Matteson DM, Li Q, et al.  Apoptosis in patients with posterior uveitis. Arch Ophthalmol. 1997;115:1559–1567
  49. Chan CC, Nussenblatt RB, Fujikawa LS, et al.  Sympathetic ophthalmia. Immunopathological findings. Ophthalmology. 1986;93:690–695
  50. Chan CC, Palestine AG, Kuwabara T, Nussenblatt RB. Immunopathologic study of Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol. 1988;105:607–611
  51. Chan CC, Palestine AG, Nussenblatt RB, et al.  Anti-retinal auto-antibodies in Vogt–Koyanagi–Harada syndrome, Behçet's disease, and sympathetic ophthalmia. Ophthalmology. 1985;92:1025–1028
  52. Chan CC, Wetzig RP, Palestine AG, et al.  Immunohistopathology of ocular sarcoidosis. Report of a case and discussion of immunopathogenesis. Arch Ophthalmol. 1987;105:1398–1402
  53. Charteris DG, Barton K, McCartney AC, Lightman SL. CD4+ lymphocyte involvement in ocular Behçet's disease. Autoimmunity. 1992;12:201–206
  54. Charteris DG, Champ C, Rosenthal AR, Lightman SL. Behçet's disease (activated T lymphocytes in retinal perivasculitis). Br J Ophthalmol. 1992;76:499–501
  55. Charteris DG, Lee WR. Multifocal posterior uveitis (clinical and pathological findings). Br J Ophthalmol. 1990;74:688–693
  56. Chavis PS, Tabbara KF. Behçet's disease. Int Ophthalmol Clin. 1995;35:43–67
  57. Check IJ, Diddie KR, Jay WM, et al.  Lymphocyte stimulation by yeast phase Histoplasma capsulatum in presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1979;87:311–316
  58. Chester GH, Blach RK, Cleary PE. Inflammation in the region of the vitreous base. Pars planitis. Trans Ophthalmol Soc UK. 1976;96:151–157
  59. Chung YM, Liu JH, Tsi ST. Behçet's disease in Taiwan—a review of 53 cases. Jpn J Ophthalmol. 1986;30:318–323
  60. Clearkin LG, Hung SO. Acute posterior multifocal placoid pigment epitheliopathy associated with transient hearing loss. Trans Ophthalmol Soc UK. 1983;103:562–564
  61. Cohen S, Kremer I. Bilateral corneal immune ring opacity in Behçet's syndrome. Arch Ophthalmol. 1991;109:324–325
  62. Constantino T, Digre K, Zimmerman P. Neuro-ophthalmic complications of sarcoidosis. Semin Neurol. 2000;20:123–137
  63. Cook BE, Robertson DM. Confluent choroidal infiltrates with sarcoidosis. Retina. 2000;20:1–7
  64. Coulie PG, Brichard V, Van Pel A, et al.  A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med. 1994;180:35–42
  65. Culbertson WW, Giles CL, West C, Stafford T. Familial pars planitis. Retina. 1983;3:179–181
  66. Damian RT. Molecular mimicry (parasite evasion and host defense). Curr Top Microbiol Immunol. 1989;145:101–115
  67. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Prognosticators for visual outcome in sarcoid uveitis. Ophthalmology. 1996;103:1846–1853
  68. Davies UM, Palmer RG, Denman AM. Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome (a randomized double-blind trial). Br J Rheumatol. 1998;27:300–302
  69. Davis JL, Mittal KK, Freidlin V, et al.  HLA associations and ancestry in Vogt–Koyanagi–Harada disease and sympathetic ophthalmia. Ophthalmology. 1990;97:1137–1142
  70. Davis JL, Mittal KK, Nussenblatt RB. HLA in intermediate uveitis. Dev Ophthalmol. 1992;23:35–37
  71. Davis JL, Solomon D, Nussenblatt RB, et al.  Immunocytochemical staining of vitreous cells. Indications, techniques, and results. Ophthalmology. 1992;99:250–256
  72. de Smet MD, Dayan M. Prospective determination of T-cell responses to S-antigen in Behçet's disease patients and controls. Invest Ophthalmol Vis Sci. 2000;41:3480–3484
  73. de Smet MD, Yamamoto JH, Mochizuki M, et al.  Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol. 1990;110:135–142
  74. de Waal LP, Lardy NM, van der Horst AR, et al.  HLA-A29 subtypes and birdshot chorioretinopathy. Immunogenetics. 1992;35:51–53
  75. Denman AM, Pelton BK, Hylton W, et al.  Herpes simplex virus and the rheumatic diseases. Rheumatol Int. 1989;9:143–146
  76. Desarnaulds AB, Borruat FX, Herbort CP, Spertini F: [Multiple evanescent white dot syndrome: a genetic predisposition?]. Klin Monatsbl Augenheilkd 208:301–2, 1996
  77. Deutman AF, Oosterhuis JA, Boen-Tan TN, Aan de Kerk AL. Acute posterior multifocal placoid pigment epitheliopathy. Pigment epitheliopathy of choriocapillaritis?. Br J Ophthalmol. 1972;56:863–874
  78. Dick AD, Cheng YF, Liversidge J, Forrester JV. Immunomodulation of experimental autoimmune uveoretinitis (a model of tolerance induction with retinal antigens). Eye. 1994;8:52–59
  79. Dinowitz K, Aldave AJ, Lisse JR, Trocme SD. Ocular manifestations of immunologic and rheumatologic inflammatory disorders. Curr Opin Ophthalmol. 1994;5:91–98
  80. Direskeneli H, Eksioglu-Demiralp E, Yavuz S, et al.  T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease. J Rheumatol. 2000;27:708–713
  81. Dithmar S, Waring GO, Goldblum TA, Grossniklaus HE. Conjunctival deposits as an initial manifestation of sarcoidosis. Am J Ophthalmol. 1999;128:361–362
  82. Doekes G, van der Gaag R, Rothova A, et al.  Humoral and cellular immune responsiveness to human S-antigen in uveitis. Curr Eye Res. 1987;6:909–919
  83. Duinkerke-Eerola KU, Pinckers A, Cruysberg JR. Pars planitis in father and son. Ophthalmic Paediatr Genet. 1990;11:305–308
  84. Duke-Elder S, Perkins ES. Sympathetic ophthalmitis. In:  Duke-Elder S editors. Diseases of the uveal tract. St Louis: Mosby; 1966;p. 558–593
  85. Dumonde DC, Kasp-Grochowska E, Graham E, et al.  Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet. 1982;2:787–792
  86. Dunlop AA, Cree IA, Hague S, et al.  Multifocal choroiditis (clinicopathologic correlation). Arch Ophthalmol. 1998;116:801–803
  87. Easom HA, Zimmerman LE. Sympathetic ophthalmia and bilateral phacoanaphylaxis. Arch Ophthalmol. 1964;72:9–15
  88. Edelstein C, D'Cruz D, Hughes GR. Anti-endothelial cell antibodies in retinal vasculitis. Curr Eye Res. 1992;11:203–208
  89. Eichenbaum JW, Friedman AH, Mamelok AE. A clinical and histopathological review of intermediate uveitis (pars planitis). Bull NY Acad Med. 1988;64:164–174
  90. Elschnig A. Studien zur sympatheschen ophthalmie (I. Wirkung von antigen vom augeninnern aus). Arch Ophthalmol. 1910;75:459–473
  91. Erem C, Uslu T, Deger O, et al.  Increased plasma lipoprotein (a) concentrations in Behçet's disease and its relation to vascular events. Heart. 2000;84:208–209
  92. Esin S, Gul A, Hodara V, et al.  Peripheral blood T cell expansions in patients with Behçet's disease. Clin Exp Immunol. 1997;107:520–527
  93. Faris BM, Foster CS. Behçet's Disease. In:  Albert D,  Jakobiec F editor. Principles & practice of ophthalmology. Philadelphia: WB Saunders and Co; 1996;p. 1018–1026
  94. Farr AK, Jabs DA, Green WR. Optic disc sarcoid granuloma. Arch Ophthalmol. 2000;118:728–729
  95. Faure JP. Autoimmunity and the retina. Curr Top Eye Res. 1980;2:215–302
  96. Felder KS, Brockhurst RJ. Neovascular fundus abnormalities in peripheral uveitis. Arch Ophthalmol. 1982;100:750–754
  97. Fidler H, Rook GA, Johnson NM, McFadden JJ. Search for mycobacterial DNA in granulomatous tissues from patients with sarcoidosis using the polymerase chain reaction. Am Rev Respir Dis. 1993;147:777–778
  98. Fidler HM, Rook GA, Johnson NM, McFadden J. Mycobacterium tuberculosis DNA in tissue affected by sarcoidosis. BMJ. 1993;306:546–549
  99. Font RL, Fine BS, Messmer E, Rowsey JF. Light and electron microscopic study of Dalen-Fuchs nodules in sympathetic ophthalmia. Ophthalmology. 1983;90:66–75
  100. Forrester JV. Autoimmunity and autoimmune disease of the eye. Dev Ophthalmol. 1999;30:167–186
  101. Forrester JV, McMenamin PG. Immunopathogenic mechanisms in intraocular inflammation. Chem Immunol. 1999;73:159–185
  102. Fortune F, Walker J, Lehner T. The expression of gamma delta T cell receptor and the prevalence of primed, activated and IgA-bound T cells in Behçet's syndrome. Clin Exp Immunol. 1990;82:326–332
  103. Franks WA, Limb GA, Stanford MR, et al.  Cytokines in human intraocular inflammation. Curr Eye Res. 1992;11(Suppl):187–191
  104. Fresko I, Yurdakul S, Hamuryudan V. The management of Behçet's syndrome. Ann Med Interne (Paris). 1999;150:576–581
  105. Freysdottir J, Lau S, Fortune F. Gammadelta T cells in Behçet's disease (BD) and recurrent aphthous stomatitis (RAS). Clin Exp Immunol. 1999;118:451–457
  106. Gasch AT, Foster CS, Grosskreutz CL. Postoperative sympathetic ophthalmia. Int Ophthalmol Clin. 2000;40:69–84
  107. Gass JD. Acute zonal occult outer retinopathy. Donders Lecture (The Netherlands Ophthalmological Society, Maastricht, Holland, June 19, 1992). J Clin Neuroophthalmol. 1993;13:79–97
  108. Gass JD. Vitiliginous chorioretinitis. Arch Ophthalmol. 1981;99:1778–1787
  109. Gass JD. Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol. 1968;80:177–185
  110. Gass JD, Olson CL. Sarcoidosis with optic nerve and retinal involvement. Arch Ophthalmol. 1976;94:945–950
  111. Genain CP, Cannella B, Hauser SL, Raine CS. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med. 1999;5:170–175
  112. George RK, Chan CC, Whitcup SM, Nussenblatt RB. Ocular immunopathology of Behçet's disease. Surv Ophthalmol. 1997;42:157–162
  113. Gilbert JG, Craig EL, Long JW. The day care center (an alternative to institutionalization of the elderly). Palestra Oftalmol Pan Am. 1977;1:71–77
  114. Giles CL. Uveitis in childhood—part III. Posterior. Ann Ophthalmol. 1989;21:23–28
  115. Giles CL. Peripheral uveitis in patients with multiple sclerosis. Am J Ophthalmol. 1970;70:17–19
  116. Goldgeier MH, Klein LE, Klein-Angerer S, et al.  The distribution of melanocytes in the leptomeninges of the human brain. J Invest Dermatol. 1984;82:235–238
  117. Goldstein BG, Buettner H. Histoplasmic endophthalmitis. A clinicopathologic correlation. Arch Ophthalmol. 1983;101:774–777
  118. Goto H, Rao NA. Sympathetic ophthalmia and Vogt–Koyanagi–Harada syndrome. Int Ophthalmol Clin. 1990;30:279–285
  119. Graham EM, Stanford MR, Shilling JS, Sanders MD. Neovascularisation associated with posterior uveitis. Br J Ophthalmol. 1987;71:826–833
  120. Gran B, Hemmer B, Vergelli M, et al.  Molecular mimicry and multiple sclerosis (degenerate T-cell recognition and the induction of autoimmunity). Ann Neurol. 1999;45:559–567
  121. Green WR, Bon Sool Koo . Behçet's disease. A report of the ocular histopathology of one case. Surv Ophthalmol. 1967;12:324–332
  122. Green WR, Kincaid MC, Michels RG, et al.  Pars planitis. Trans Ophthalmol Soc UK. 1981;101:361–367
  123. Green WR, Maumenee AE, Sanders TE, Smith ME. Sympathetic uveitis following evisceration. Trans Am Acad Ophthalmol Otolaryngol. 1972;76:625–644
  124. Gruber R, Pforte A, Beer B, Riethmuller G. Determination of gamma/delta and other T-lymphocyte subsets in bronchoalveolar lavage fluid and peripheral blood from patients with sarcoidosis and idiopathic fibrosis of the lung. APMIS. 1996;104:199–205
  125. Gul A, Esin S, Dilsen N, et al.  Immunohistology of skin pathergy reaction in Behçet's disease. Br J Dermatol. 1995;132:901–907
  126. Gupta RC, ODuffy JD, McDuffie FC, et al.  Circulating immune complexes in active Behçet's disease. Clin Exp Immunol. 1978;34:213–218
  127. Halbert SP, Manski W, Ehrlich G. Autoimmunization in the eye. Ann NY Acad Sci. 1965;124:332–351
  128. Hammer H. Lymphocyte transformation test in sympathetic ophthalmitis and the Vogt– Koyanagi–Harada syndrome. Br J Ophthalmol. 1971;55:850–852
  129. Hamza M, Elleuch M, Slim A, et al.  Antibodies to herpes simplex virus in patients with Behçet's disease. Clin Rheumatol. 1990;9:498–500
  130. Hamza M, Slim A. Herpes simplex virus antigens in sera of patients with Behçet's disease. Clin Rheumatol. 1991;10:456
  131. Hamzaoui K, Ayed K, Slim A, et al.  Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease. Clin Exp Immunol. 1990;79:28–34
  132. Hamzaoui K, Hamzaoui A, Hentati F, et al.  Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behçet's disease. J Rheumatol. 1994;21:2301–2306
  133. Hamzaoui K, Hamzaoui A, Zakraoui L, Chabbou A. Expression of Bcl-2 in inflammatory sites from patients with active Behçet's disease. Mediators Inflamm. 1999;8:101–106
  134. Hamzaoui K, Kahan A, Ayed K, Hamza M. Cytotoxic T cells against herpes simplex virus in Behçet's disease. Clin Exp Immunol. 1990;81:390–395
  135. Hancock WW, Kobzik L, Colby AJ, et al.  Detection of lymphokines and lymphokine receptors in pulmonary sarcoidosis. Immunohistologic evidence that inflammatory macrophages express IL-2 receptors. Am J Pathol. 1986;123:1–8
  136. Hasan A, Fortune F, Wilson A, et al.  Role of gamma delta T cells in pathogenesis and diagnosis of Behçet's disease. Lancet. 1996;347:789–794
  137. Hausmann S, Wucherpfennig KW. Activation of autoreactive T cells by peptides from human pathogens. Curr Opin Immunol. 1997;9:831–838
  138. Haznedaroglu E, Karaaslan Y, Buyukasik Y, et al.  Selectin adhesion molecules in Behçet's disease. Ann Rheum Dis. 2000;59:61–63
  139. Hegab S, Al-Mutawa S. Immunopathogenesis of Behçet's disease. Clin Immunol. 2000;96:174–186
  140. Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol. 1987;103:131–136
  141. Henderly DE, Haymond RS, Rao NA, Smith RE. The significance of the pars plana exudate in pars planitis. Am J Ophthalmol. 1987;103:669–671
  142. Henke CE, Henke G, Elveback LR, et al.  The epidemiology of sarcoidosis in Rochester, Minnesota (a population-based study of incidence and survival). Am J Epidemiol. 1986;123:840–845
  143. Hirohata S, Hashimoto T. Abnormal T cell responses to bacterial superantigens in Behçet's disease (BD). Clin Exp Immunol. 1998;112:317–324
  144. Hirohata T, Kuratsune M, Nomura A, Jimi S. Prevalence of Behçet's syndrome in Hawaii. With particular reference to the comparison of the Japanese in Hawaii and Japan. Hawaii Med J. 1975;34:244–246
  145. Hogan MJ, Kimura SJ, OConnor GR. Peripheral retinitis and chronic cyclitis in children. Trans Ophthalmol Soc UK. 1965;85:39–52
  146. Hooks JJ, Chan CC, Detrick B. Identification of the lymphokines, interferon-gamma and interleukin-2, in inflammatory eye diseases. Invest Ophthalmol Vis Sci. 1988;29:1444–1451
  147. Hooks JJ, Moutsopoulos HM, Geis SA, et al.  Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med. 1979;301:5–8
  148. Hull RG, Harris EN, Gharavi AE, et al.  Anticardiolipin antibodies (occurrence in Behçet's syndrome). Ann Rheum Dis. 1984;43:746–748
  149. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis (a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity). N Engl J Med. 1981;305:429–434
  150. Hunter DG, Foster CS. Ocular manifestations of sarcoidosis. In:  Albert D,  Jakobiec F editor. Principles & practice of ophthalmology. Philadelphia: WB Saunders and Co; 1996;p. 443–449
  151. Hunter DG, Foster CS. Systemic manifestations of sarcoidosis. In:  Albert D,  Jakobiec F editor. Principles & practice of ophthalmology. Philadelphia: WB Saunders and Co; 1996;p. 3132–3141
  152. Hylkema HA. The role of the immune system in uveitis induced in animals. Doc Ophthalmol. 1988;70:339–351
  153. Imai Y: [The prognosis on Behçet's disease under long period of observation]. Nippon Ganka Gakkai Zasshi 74:1118–20, 1970
  154. Inomata H. Necrotic changes of choroidal melanocytes in sympathetic ophthalmia. Arch Ophthalmol. 1988;106:239–242
  155. Inomata H, Sakamoto T. Immunohistochemical studies of Vogt–Koyanagi–Harada disease with sunset sky fundus. Curr Eye Res. 1990;9(Suppl):35–40
  156. Inoue C, Itoh R, Kawa Y, Mizoguchi M. Pathogenesis of mucocutaneous lesions in Behçet's disease. J Dermatol. 1994;21:474–480
  157. Irvine AR, Spencer WH, Hogan MJ, et al.  Presumed chronic ocular histoplasmosis syndrome (a clinical-pathologic case report). Trans Am Ophthalmol Soc. 1977;74:91–106
  158. Ishige I, Usui Y, Takemura T, Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet. 1999;354:120–123
  159. Ishihara M, Ohno S. Genetic influences on sarcoidosis. Eye. 1997;11:155–161
  160. Isogai E, Isogai H, Yokota K, et al.  Platelet aggregation induced by uncommon serotypes of Streptococcus sanguis isolated from patients with Behçet's disease. Arch Oral Biol. 1991;36:425–429
  161. Itho S, Kurimoto S, Kouno T. Vogt–Koyanagi–Harada disease in monozygotic twins. Int Ophthalmol. 1992;16:49–54
  162. Itoh R, Takenaka T, Okitsu-Negishi S, et al.  Interleukin 8 in Behçet's disease. J Dermatol. 1994;21:397–404
  163. Iwata K, Nanba K, Sobue K, Abe H. Ocular sarcoidosis (evaluation of intraocular findings). Ann NY Acad Sci. 1976;278:445–454
  164. Izmerov NF, Volkova NI: [Development of scientific studies on industrial hygiene and occupational pathology]. Gig Tr Prof Zabol 16:34–9, 1972
  165. Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol. 1986;102:297–301
  166. Jakobiec FA, Lefkowitch J, Knowles DM. B- and T-lymphocytes in ocular disease. Ophthalmology. 1984;91:635–654
  167. Jakobiec FA, Marboe CC, Knowles DM, et al.  Human sympathetic ophthalmia. An analysis of the inflammatory infiltrate by hybridoma-monoclonal antibodies, immunochemistry, and correlative electron microscopy. Ophthalmology. 1983;90:76–95
  168. James DG, Friedmann AI, Graham E. Uveitis. A series of 368 patients. Trans Ophthalmol Soc UK. 1976;96:108–112
  169. James DG, Neville E, Langley DA. Ocular sarcoidosis. Trans Ophthalmol Soc UK. 1976;96:133–139
  170. James DG, Turiaf J, Hosoda Y, et al.  Description of sarcoidosis (Report of the Subcommittee on Classification and Definition). Ann NY Acad Sci. 1976;278:742
  171. James DG, Williams WJ. Immunology of sarcoidosis. Am J Med. 1982;72:5–8
  172. Jampol LM, Isenberg SJ, Goldberg MF. Occlusive retinal arteriolitis with neovascularization. Am J Ophthalmol. 1976;81:583–589
  173. Jampol LM, Sieving PA, Pugh D, et al.  Multiple evanescent white dot syndrome. I. Clinical findings. Arch Ophthalmol. 1984;102:671–674
  174. Jampol LM, Wiredu A. Mewds, mfc, pic, amn, aibse, and azoor (one disease or many?). Retina. 1995;15:373–378
  175. Kutte A, Lemke L, Opitz J: [Chronic cyclitis in children]. Ophthalmologica 157:169–77, 1969
  176. Kabelitz D, Wesch D, Hinz T. gamma delta T cells, their T cell receptor usage and role in human diseases. Springer Semin Immunopathol. 1999;21:55–75
  177. Kahan A, Hamzaoui K, Ayed K. Abnormalities of T lymphocyte subsets in Behçet's disease demonstrated with anti-CD45RA and anti-CD29 monoclonal antibodies. J Rheumatol. 1992;19:742–746
  178. Kahn M, Pepose JS, Green WR, et al.  Immunocytologic findings in a case of Vogt–Koyanagi–Harada syndrome. Ophthalmology. 1993;100:1191–1198
  179. Kaneko F, Takahashi Y, Muramatsu Y, Miura Y. Immunological studies on aphthous ulcer and erythema nodosum-like eruptions in Behçet's disease. Br J Dermatol. 1985;113:303–312
  180. Kaplan HJ, Aaberg TM. Birdshot retinochoroidopathy. Am J Ophthalmol. 1980;90:773–782
  181. Kaplan HJ, Aaberg TM, Keller RH. Recurrent clinical uveitis. Cell surface markers on vitreous lymphocytes. Arch Ophthalmol. 1982;100:585–587
  182. Karma A. Ophthalmic changes in sarcoidosis. Acta Ophthalmol (Suppl). 1979;141:1–94
  183. Karma A, Taskinen E, Kainulainen H, Partanen M. Phenotypes of conjunctival inflammatory cells in sarcoidosis. Br J Ophthalmol. 1992;76:101–106
  184. Katsantonis J, Adler Y, Orfanos CE, Zouboulis CC. Adamantiades-Behçet's disease (serum IL-8 is a more reliable marker for disease activity than C-reactive protein and erythrocyte sedimentation rate). Dermatology. 2000;201:37–39
  185. Kawakami Y, Eliyahu S, Delgado CH, et al.  Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA. 1994;91:6458–6462
  186. Kaye GB, Salmon JF, Isaacs S. Risk factors for uveitis in sarcoidosis. S Afr Med J. 1993;83:342–344
  187. Keino H, Sakai J, Nishioka K, et al.  Clonally accumulating T cells in the anterior chamber of Behçet disease. Am J Ophthalmol. 2000;130:243–245
  188. Kelley JS, Green WR. Sarcoidosis involving the optic nerve head. Arch Ophthalmol. 1973;89:486–488
  189. Kelly PJ, Weiter JJ. Resolution of optic disk neovascularization associated with intraocular inflammation. Am J Ophthalmol. 1980;90:545–548
  190. Khalil MK. Histopathology of presumed ocular histoplasmosis. Am J Ophthalmol. 1982;94:369–376
  191. Kilmartin DJ, Dick AD, Forrester JV. Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol. 2000;84:259–263
  192. Kilmartin DJ, Dick AD, Forrester JV. Sympathetic ophthalmia risk following vitrectomy (should we counsel patients?). Br J Ophthalmol. 2000;84:448–449
  193. Kim MH, Seong MC, Kwak NH, et al.  Association of HLA with Vogt–Koyanagi–Harada syndrome in Koreans. Am J Ophthalmol. 2000;129:173–177
  194. Kimura T, Goto K, Yabuki K, et al.  Microsatellite polymorphism within the MICB gene among Japanese patients with Behçet's disease. Hum Immunol. 1998;59:500–502
  195. Klintworth GK, Hollingsworth AS, Lusman PA, et al.  Granulomatous choroiditis in a case of disseminated histoplasmosis. Histologic demonstration of Histoplasma capsulatum in choroidal lesions. Arch Ophthalmol. 1973;90:45–48
  196. Klok AM, Luyendijk L, Zaal MJ, et al.  Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis. Br J Ophthalmol. 1998;82:871–874
  197. Kobayashi M, Ito M, Nakagawa A, et al.  Neutrophil and endothelial cell activation in the vasa vasorum in vasculo-Behçet disease. Histopathology. 2000;36:362–371
  198. Kong AS, Henley WL, Luntz MH. Longitudinal study of serum antibody response to bovine corneal protein (BCP 54) in Behçet's disease. Ophthalmic Res. 1989;21:401–405
  199. Krause I, Blank M, Shoenfeld Y. Immunomodulation of experimental autoimmune diseases via oral tolerance. Crit Rev Immunol. 2000;20:1–16
  200. Kuhne F, Morlat P, Riss I, et al: [Is A29, B12 vasculitis caused by the Q fever agent? (Coxiella burnetii)]. J Fr Ophtalmol 15:315–21, 1992
  201. Kukreja A, Maclaren NK. Autoimmunity and diabetes. J Clin Endocrinol Metab. 1999;84:4371–4378
  202. Kuo IC, Rechdouni A, Rao NA, et al.  Subretinal fibrosis in patients with Vogt–Koyanagi–Harada disease. Ophthalmology. 2000;107:1721–1728
  203. Kuo PK, Lubin JR, Ni C, et al.  Sympathetic ophthalmia (a comparison of the histopathological features from a Chinese and American series). Int Ophthalmol Clin. 1982;22:125–139
  204. Kuppner MC, Liversidge J, McKillop-Smith S, et al.  Adhesion molecule expression in acute and fibrotic sympathetic ophthalmia. Curr Eye Res. 1993;12:923–934
  205. Kurhan-Yavuz S, Direskeneli H, Bozkurt N, et al.  Anti-MHC autoimmunity in Behçet's disease (T cell responses to an HLA-B- derived peptide cross-reactive with retinal-S antigen in patients with uveitis). Clin Exp Immunol. 2000;120:162–166
  206. Le Hoang P, Girard B, Deray G, et al.  Cyclosporine in the treatment of birdshot retinochoroidopathy. Transplant Proc. 1988;20:128–130
  207. Lee S, Bang D, Cho YH, et al.  Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet's disease. Arch Dermatol Res. 1996;288:179–183
  208. Lehmann PV, Forsthuber T, Miller A, Sercarz EE. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 1992;358:155–157
  209. Lehmann PV, Sercarz EE, Forsthuber T, et al.  Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today. 1993;14:203–208
  210. Lehner T. The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behçet's disease. Int Rev Immunol. 1997;14:21–32
  211. Lehner T, Lavery E, Smith R, et al.  Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome. Infect Immun. 1991;59:1434–1441
  212. LeHoang P, Cassoux N, George F, et al.  Intravenous immunoglobulin (IVIg) for the treatment of birdshot retinochoroidopathy. Ocul Immunol Inflamm. 2000;8:49–57
  213. LeHoang P, Ozdemir N, Benhamou A, et al.  HLA-A29.2 subtype associated with birdshot retinochoroidopathy. Am J Ophthalmol. 1992;113:33–35
  214. Lertsumitkul S, Whitcup SM, Nussenblatt RB, Chan CC. Subretinal fibrosis and choroidal neovascularization in Vogt–Koyanagi- Harada syndrome. Graefes Arch Clin Exp Ophthalmol. 1999;237:1039–1045
  215. Liddy L, Stuart J. Sympathetic ophthalmia in Canada. Can J Ophthalmol. 1972;7:157–159
  216. Lim JI, Kokame GT, Douglas JP. Multiple evanescent white dot syndrome in older patients. Am J Ophthalmol. 1999;127:725–728
  217. Liu T, Sun SM: [Peripheral lymphocyte subsets in patients with Vogt–Koyanagi–Harada syndrome (VKH)]. Chung Hua Yen Ko Tsa Chih 29:138–40, 1993
  218. Lubin JR, Albert DM, Weinstein M. Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of. 1980;105(cases (1913–1978). Ophthalmology 87):109–121
  219. Lubin JR, Ni C, Albert DM. Clinicopathological study of the Vogt–Koyanagi–Harada syndrome. Int Ophthalmol Clin. 1982;22:141–156
  220. Maezawa N, Yano A. Two distinct cytotoxic T lymphocyte subpopulations in patients with Vogt–Koyanagi–Harada disease that recognize human melanoma cells. Microbiol Immunol. 1984;28:219–231
  221. Maliarik MJ, Chen KM, Major ML, et al.  Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis. Am J Respir Crit Care Med. 1998;158:111–114
  222. Malinowski SM, Pulido JS, Folk JC. Long-term visual outcome and complications associated with pars planitis. Ophthalmology. 1993;100:818–824
  223. Malinowski SM, Pulido JS, Goeken NE, et al.  The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology. 1993;100:1199–1205
  224. Marak GE. Recent advances in sympathetic ophthalmia. Surv Ophthalmol. 1979;24:141–156
  225. Marak GE, Font RL, Johnson MC, Alepa FP. Lymphocyte-stimulating activity of ocular tissues in sympathetic ophthalmia. Invest Ophthalmol. 1971;10:770–774
  226. Margo CE, Pautler SE. Granulomatous uveitis after treatment of a choroidal melanoma with proton-beam irradiation. Retina. 1990;10:140–143
  227. Martin DF, Chan CC, de Smet MD, et al.  The role of chorioretinal biopsy in the management of posterior uveitis. Ophthalmology. 1993;100:705–714
  228. Martin T, Weber M, Schmitt C, et al.  Association of intermediate uveitis with HLA-A28 (definition of a new systemic syndrome?). Graefes Arch Clin Exp Ophthalmol. 1995;233:269–274
  229. Masuda K, Inaba G, Mizushima H. A nationwide survey of Behçet's disease in Japan. Jpn J Ophthalmol. 1974;19:278–285
  230. Masuda K, Nakajima A, Urayama A, et al.  Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet. 1989;1:1093–1096
  231. Matsuda H: [Electron microscopic studies on Vogt–Koyanagi–Harada syndrome and sympathetic ophthalmia with special reference to the melanocyte]. Nippon Ganka Gakkai Zasshi 74:1107–12, 1970
  232. Maumenee AE. Clinical entities in uveitis (an approach to the study of intraocular inflammation). Trans Am Acad Ophthalmol Otolaryngol. 1970;74:473–504
  233. McClellan KA, MacDonald M, Hersey P, Billson FA. Vogt–Koyanagi–Harada syndrome—isolation of cloned T cells with specificity for melanocytes and melanoma cells. Aust NZ J Ophthalmol. 1989;17:347–352
  234. McFadden JJ, Fidler HM. Mycobacteria as possible causes of sarcoidosis and Crohns disease. Soc Appl Bacteriol Symp Ser. 1996;25:47S–52S
  235. Meredith TA, Green WR, Key SN, et al.  Ocular histoplasmosis (clinicopathologic correlation of 3 cases). Surv Ophthalmol. 1977;22:189–205
  236. Meredith TA, Smith RE, Duquesnoy RJ. Association of HLA-DRw2 antigen with presumed ocular histoplasmosis. Am J Ophthalmol. 1980;89:70–76
  237. Milburn HJ, Poulter LW, Dilmec A, et al.  Corticosteroids restore the balance between locally produced Th1 and Th2 cytokines and immunoglobulin isotypes to normal in sarcoid lung. Clin Exp Immunol. 1997;108:105–113
  238. Mishima S, Masuda K, Izawa Y, et al.  The eighth Frederick H. Verhoeff Lecture. presented by Saiichi Mishima, MD Behçet's disease in Japan (ophthalmologic aspects). Trans Am Ophthalmol Soc. 1979;77:225–279
  239. Mitchell DN, Scadding JG. Sarcoidosis. Am Rev Respir Dis. 1974;110:774–802
  240. Mitchell DN, Scadding JG, Heard BE, Hinson KF. Sarcoidosis (histopathological definition and clinical diagnosis). J Clin Pathol. 1977;30:395–398
  241. Miyao A, Ikeda T, Matsumoto Y, et al.  Histopathological findings in proliferative membrane from a patient with sarcoid uveitis. Jpn J Ophthalmol. 1999;43:209–212
  242. Mizuki N, Inoko H, Ohno S. Molecular genetics (HLA) of Behçet's disease. Yonsei Med J. 1997;38:333–349
  243. Mizuki N, Ohno S. Immunogenetic studies of Behçet's disease. Rev Rhum Engl Ed. 1996;63:520–527
  244. Mizuki N, Ota M, Katsuyama Y, et al.  Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. Arthritis Rheum. 1999;42:1961–1966
  245. Mochizuki M. Immunotherapy for Behçet's disease. Int Rev Immunol. 1997;14:49–66
  246. Mochizuki M, Watanabe T, Yamaguchi K, et al.  Uveitis associated with human T-cell lymphotropic virus type I. Am J Ophthalmol. 1992;114:123–129
  247. Mokhtarian F, Zhang Z, Shi Y, et al.  Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice. J Neuroimmunol. 1999;95:43–54
  248. Moller DR, Forman JD, Liu MC, et al.  Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol. 1996;156:4952–4960
  249. Moorthy RS, Inomata H, Rao NA. Vogt–Koyanagi–Harada syndrome. Surv Ophthalmol. 1995;39:265–292
  250. Moreira MB, Moreira CA: [Virus search in cerebrospinal fluid in Vogt–Koyanagi syndrome: report of a case]. Arq Neuropsiquiatr 42:408–10, 1984
  251. Morel PA, Oriss TB. Crossregulation between Th1 and Th2 cells. Crit Rev Immunol. 1998;18:275–303
  252. Morris W, Schlagel TF. Virus-like inclusion bodies in subretinal fluid in uveo-encephalitis. Am J Ophthalmol. 1964;58:940–945
  253. Mosmann TR, Cherwinski H, Bond MW, et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348–2357
  254. Muhaya M, Lightman S, Ikeda E, et al.  Behçet's disease in Japan and in Great Britain (a comparative study). Ocul Immunol Inflamm. 2000;8:141–148
  255. Mullaney J, Collum LM. Ocular vasculitis in Behçet's disease. A pathological and immunohistochemical study. Int Ophthalmol. 1985;7:183–191
  256. Muller-Hermelink HK, Kraus-Mackiw E, Daus W. Early stage of human sympathetic ophthalmia. Histologic and immunopathologic findings. Arch Ophthalmol. 1984;102:1353–1357
  257. Muller-Quernheim J. Sarcoidosis (immunopathogenetic concepts and their clinical application). Eur Respir J. 1998;12:716–738
  258. Nakamura S, Nakazawa M, Yoshioka M, et al.  Melanin-laden macrophages in cerebrospinal fluid in Vogt–Koyanagi–Harada syndrome. Arch Ophthalmol. 1996;114:1184–1188
  259. Namba K, Ueno T, Okita M. Behçet's disease and streptococcal infection. Jpn J Ophthalmol. 1986;30:385–401
  260. Nishida T, Hirayama K, Nakamura S, Ohno S. Proliferative response of CD8+ gamma delta+ T cells to Streptococcus sanguis in patients with Behçet's disease. Ocul Immunol Inflamm. 1998;6:139–144
  261. Nishino K, Yoshida H, Yoshida O, et al.  Analysis of responses of peripheral blood lymphocytes from sarcoidosis patients to purified protein derivative. Jpn J Ophthalmol. 2000;44:165–170
  262. Nolle B. Antiretinal autoantibodies in intermediate uveitis. Dev Ophthalmol. 1992;23:94–98
  263. Nolle B, Eckardt C. Vitrectomy in multifocal chorioretinitis. Ger J Ophthalmol. 1993;2:14–19
  264. Nolle B, Eckardt C. Cellular phenotype of vitreous cells in intermediate uveitis. Dev Ophthalmol. 1992;23:145–149
  265. Nolle B, Faul S, Jenisch S, Westphal E. Peripheral multifocal chorioretinitis with panuveitis (clinical and immunogenetic characterization in older patients). Graefes Arch Clin Exp Ophthalmol. 1998;236:451–460
  266. Norose K, Yano A. Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt–Koyanagi–Harada disease. Br J Ophthalmol. 1996;80:1002–1008
  267. Norose K, Yano A, Aosai F, Segawa K. Immunologic analysis of cerebrospinal fluid lymphocytes in Vogt–Koyanagi–Harada disease. Invest Ophthalmol Vis Sci. 1990;31:1210–1216
  268. Norose K, Yano A, Wang XC, et al.  Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt–Koyanagi–Harada disease. Invest Ophthalmol Vis Sci. 1994;35:33–39
  269. Nussenblatt RB. Proctor Lecture. Experimental autoimmune uveitis (mechanisms of disease and clinical therapeutic indications). Invest Ophthalmol Vis Sci. 1991;32:3131–3141
  270. Nussenblatt RB, Palestine AG, Whitcup SM, Craven L. Intermediate uveitis, in Uveitis (fundamental and clinical practice). St. Louis: Mosby; 1995;ed. 2, pp 279–88.
  271. Nussenblatt RB, Mittal KK, Ryan S, et al.  Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol. 1982;94:147–158
  272. Nussenblatt RB, Palestine AG, Whitcup SM, Craven L. Sarcoidosis, in Uveitis (fundamental and clinical practice). St Louis: Mosby; 1995;, ed 2, pp 289–98.
  273. Nussenblatt RB, Palestine AG, Whitcup SM, Craven L. Birdshot retinochoroidopathy, in Uveitis (fundamental and clinical practice). St Louis: Mosby; 1995;ed 2, pp 279–88
  274. Nussenblatt RB, Palestine AG, Whitcup SM, Craven L. Intermediate uveitis, in Uveitis (fundamental and clinical practice). St Louis: Mosby; 1995;ed 2, pp 325–33
  275. Nussenblatt RB, Palestine AG, Whitcup SM, Craven L. White-dot syndromes, in Uveitis (fundamental and clinical practice). St Louis: Mosby; 1995;ed 2, pp 371–84
  276. Nussenblatt RB, Palestine AG, Whitcup SM, Craven L. Vogt–Koyanagi–Harada Syndrome, in Uveitis (fundamental and clinical practice). St Louis: Mosby; 1995;ed 2, pp 312–24
  277. Nussenblatt RB, Palestine AG, Whitcup SM, Craven L. Sympathetic ophthalmia, in Uveitis (fundamental and clinical practice). St Louis: Mosby; 1995;ed 2, pp 299–311
  278. Nussenblatt RB, Palestine AG, Whitcup SM, Craven L. Behçet's disease, in Uveitis (fundamental and clinical practice). St Louis: Mosby; 1995;, ed 2, pp 334–53
  279. Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol. 1978;86:648–655
  280. OConnor GR. Ocular sarcoidosis. Trans New Orleans Acad Ophthalmol. 1983;31:211–222
  281. ODuffy JD, Lehner T, Barnes CG: Summary of the Third International Conference on Behçet's Disease, Tokyo, Japan, October 23–24, 1981. J Rheumatol 10:154–8, 1983
  282. Ogawa A, Sato Y, Miyasaka S, et al.  A case of proliferative sarcoid retinopathy with sarcoid nodules in tissue obtained during vitrectomy. Jpn J Ophthalmol. 2000;44:575–576
  283. Ohashi PS. T cell selection and autoimmunity (flexibility and tuning). Curr Opin Immunol. 1996;8:808–814
  284. Ohno S. Immunological aspects of Behçet's and Vogt–Koyanagi–Haradas diseases. Trans Ophthalmol Soc UK. 1981;101:335–341
  285. Ohno S. Behçet's disease in the world (recent advances in Behçet's disease). International congress and symposium series no. 1986;103(London. Royal Soc Med Serv 103):181–186
  286. Ohno S, Char DH, Kimura SJ, OConnor GR. HLA antigens and antinuclear antibody titres in juvenile chronic iridocyclitis. Br J Ophthalmol. 1977;61:59–61
  287. Ohno S, Kato F, Matsuda H, et al.  Studies on spontaneous production of gamma-interferon in Behçet's disease. Ophthalmologica. 1982;185:187–192
  288. Ohno S, Minakawa R, Matsuda H. Clinical studies of Vogt–Koyanagi–Haradas disease. Jpn J Ophthalmol. 1988;32:334–343
  289. Ohno S, Ohguchi M, Hirose S, et al.  Close association of HLA-Bw51 with Behçet's disease. Arch Ophthalmol. 1982;100:1455–1458
  290. Ohta K: [T lymphocyte subsets in aqueous humor from patients with uveitis]. Nippon Ganka Gakkai Zasshi 100:899–904, 1996
  291. Ohta K, Yoshimura N. Expression of Fas antigen on helper T lymphocytes in Vogt–Koyanagi–Harada disease. Graefes Arch Clin Exp Ophthalmol. 1998;236:434–439
  292. Okubo K, Kurimoto S, Okubo K, et al.  Surface markers of peripheral blood lymphocytes in Vogt–Koyanagi–Harada disease. J Clin Lab Immunol. 1985;17:49–52
  293. Okubo K, Kurimoto S, Okubo K, Yokoyama MM: [Surface marker studies of cerebrospinal fluid lymphocytes in Vogt– Koyanagi–Harada diseases]. Nippon Ganka Gakkai Zasshi 89:726–32, 1985
  294. ONeill TW, Rigby AS, Silman AJ, Barnes C. Validation of the International Study Group criteria for Behçet's disease. Br J Rheumatol. 1994;33:115–117
  295. Opremcak EM. Birdshot retinochoroiditis. In:  Albert D,  Jakobiec F editor. Principles & practice of ophthalmology. Philadelphia: WB Saunders and Co; 1996;p. 475–480
  296. Ormerod LD, Dailey JP. Ocular manifestations of cat-scratch disease. Curr Opin Ophthalmol. 1999;10:209–216
  297. Ota M, Mizuki N, Katsuyama Y, et al.  The critical region for Behçet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. Am J Hum Genet. 1999;64:1406–1410
  298. Palestine AG, Nussenblatt RB, Chan CC, et al.  Histopathology of the subretinal fibrosis and uveitis syndrome. Ophthalmology. 1985;92:838–844
  299. Palexas GN, Sussman G, Welsh NH. Ocular and systemic determination of IL-1 beta and tumour necrosis factor in a patient with ocular inflammation. Scand J Immunol. 1992;11(Suppl):173–175
  300. Paradis IL, Dauber JH, Rabin BS. Lymphocyte phenotypes in bronchoalveolar lavage and lung tissue in sarcoidosis and idiopathic pulmonary fibrosis. Am Rev Respir Dis. 1986;133:855–860
  301. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol. 1993;11:331–360
  302. Paz A, Fiszer U, Zaborski J, et al.  Phenotyping analysis of peripheral blood leukocytes in patients with multiple sclerosis. Eur J Neurol. 1999;6:347–352
  303. Pearson CI, McDevitt HO. Redirecting Th1 and Th2 responses in autoimmune disease. Curr Top Microbiol Immunol. 1999;238:79–122
  304. Pederson JE, Kenyon KR, Green WR, Maumenee AE. Pathology of pars planitis. Am J Ophthalmol. 1978;86:762–774
  305. Perkins ES, Folk J. Uveitis in London and Iowa. Ophthalmologica. 1984;189:36–40
  306. Pivetti-Pezzi P, Priori R, Catarinelli G, et al.  Markers of vascular injury in Behçet's disease associated with retinal vasculitis. Ann Ophthalmol. 1992;24:411–414
  307. Polk TD, Goldman EJ. White-dot chorioretinal inflammatory syndromes. Int Ophthalmol Clin. 1999;39:33–53
  308. Popper HH. Epithelioid cell granulomatosis of the lung (new insights and concepts). Sarcoidosis Vasc Diffuse Lung Dis. 1999;16:32–46
  309. Present DH, Siltzbach LE. Sarcoidosis among the Chinese and a review of the worldwide epidemiology of sarcoidosis. Am Rev Respir Dis. 1967;95:285–291
  310. Raja SC, Jabs DA, Dunn JP, et al.  Pars planitis (clinical features and class II HLA associations). Ophthalmology. 1999;106:594–599
  311. Rao NA. Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome. Eye. 1997;11:213–216
  312. Rathinam SR, Namperumalsamy P, Nozik RA, Cunningham ET. Vogt–Koyanagi–Harada syndrome after cutaneous injury. Ophthalmology. 1999;106:635–638
  313. Raziuddin S, al-Dalaan A, Bahabri S, et al.  Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol. 1998;25:329–333
  314. Redslob E. Considerations anciennes et nouvelles sur la pathologie at la pathogenie de lophthalmie sympathique. Ophthalmologica. 1949;118:483–495
  315. Reynard M, Shulman IA, Azen SP, Minckler DS. Histocompatibility antigens in sympathetic ophthalmia. Am J Ophthalmol. 1983;95:216–221
  316. Rizzi R, Bruno S, Dammacco R. Behçet's disease (an immune-mediated vasculitis involving vessels of all sizes). Int J Clin Lab Res. 1997;27:225–232
  317. Robinson BW, McLemore TL, Crystal RG. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest. 1985;75:1488–1495
  318. Robinson DS, Hamid Q, Ying S, et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992;326:298–304
  319. Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol. 2000;85:9–18; quiz 18, 21
  320. Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis. 1999;5:285–294
  321. Romagnani S. The Th1/Th2 paradigm. Immunol Today. 1997;18:263–266
  322. Romagnani S. Human TH1 and TH2 subsets (doubt no more). Immunol Today. 1991;12:256–257
  323. Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol. 2000;84:110–116
  324. Rothova A, Alberts C, Glasius E, et al.  Risk factors for ocular sarcoidosis. Doc Ophthalmol. 1989;72:287–296
  325. Rothova A, Van Schooneveld MJ. The end stage of birdshot retinochoroidopathy. Br J Ophthalmol. 1995;79:1058–1059
  326. Rubio JP, Speed TP, Bahlo M, et al.  The current state of multiple sclerosis genetic research. Ann Acad Med Singapore. 2000;29:322–330
  327. Rubsamen PE, Gass JD. Vogt–Koyanagi–Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol. 1991;109:682–687
  328. Ryan SJ. Histopathological correlates of presumed ocular histoplasmosis. Int Ophthalmol Clin. 1975;15:125–137
  329. Ryan SJ, Maumenee AE. Birdshot retinochoroidopathy. Am J Ophthalmol. 1980;89:31–45
  330. Ryan SJ, Maumenee AE. Acute posterior multifocal placoid pigment epitheliopathy. Am J Ophthalmol. 1972;74:1066–1074
  331. Rybicki BA, Maliarik MJ, Major M, et al.  Genetics of sarcoidosis. Clin Chest Med. 1997;18:707–717
  332. Saboor SA, Johnson NM, McFadden J. Detection of mycobacterial DNA in sarcoidosis and tuberculosis with polymerase chain reaction. Lancet. 1992;339:1012–1015
  333. Saenz A, Ausejo M, Shea B: Pharmacotherapy for Behçet's syndrome. Cochrane Database Syst Rev 2000;(2):CD001084
  334. Sakamoto T, Murata T, Inomata H. Class II major histocompatibility complex on melanocytes of Vogt–Koyanagi–Harada disease. Arch Ophthalmol. 1991;109:1270–1274
  335. Sakane T, Kotani H, Takada S, Tsunematsu T. Functional aberration of T cell subsets in patients with Behçet's disease. Arthritis Rheum. 1982;25:1343–1351
  336. Sakane T, Suzuki N, Nagafuchi H. Etiopathology of Behçet's disease (immunological aspects). Yonsei Med J. 1997;38:350–358
  337. Sakane T, Takeno M. Novel approaches to Behçet's disease. Expert Opin Investig Drugs. 2000;9:1993–2005
  338. Sakane T, Takeno M. Drug treatments for skin disease introduced in 1999. Skin Ther Lett. 2000;5:3–4
  339. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med. 1999;341:1284–1291
  340. Sartwell PE, Edwards LB. Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol. 1974;99:250–257
  341. Sasamoto Y, Kawano Y, Wiggert B, et al.  Induction of unresponsiveness in adult rats by immunodominant and nondominant peptides. Cell Immunol. 1993;152:286–292
  342. Sasamoto Y, Kawano YI, Bouligny R, et al.  Immunomodulation of experimental autoimmune uveoretinitis by intravenous injection of uveitogenic peptides. Invest Ophthalmol Vis Sci. 1992;33:2641–2649
  343. Sayinalp N, Ozcebe OI, Ozdemir O, et al.  Cytokines in Behçet's disease. J Rheumatol. 1996;23:321–322
  344. Saylan T, Mat C, Fresko I, et al.  Behçet's disease in the Middle East. Clin Dermatol. 1999;17:209–223
  345. Schlaegel TF. Eye histoplasmosis. Ann Ophthalmol. 1979;11:1645–1654
  346. Schreck E: [Further investigations for the demonstration of a specific microorganism in sympathetik ophthalmia]. Albrecht Von Graefes Arch Klin Exp Ophthalmol 193:229–43, 1975
  347. Seder RA, Le Gros GG. The functional role of CD8+ T helper type 2 cells. J Exp Med. 1995;181:5–7
  348. Semenzato G, Pezzutto A, Chilosi M, Pizzolo G. Redistribution of T lymphocytes in the lymph nodes of patients with sarcoidosis. N Engl J Med. 1982;306:48–49
  349. Semenzato G, Pezzutto A, Pizzolo G, et al.  Immunohistological study in sarcoidosis (evaluation at different sites of disease activity). Clin Immunol Immunopathol. 1984;30:29–40
  350. Shah DN, Piacentini MA, Burnier MN. Inflammatory cellular kinetics in sympathetic ophthalmia (a study of traumatized (exciting) eyes). Ocul Immunol Inflamm. 1993;1:255–262
  351. Sharma OP. Sarcoidosis. Dis Mon. 1990;36:469–535
  352. Shigehara K, Shijubo N, Nakanishi F, et al.  Circulating gamma delta-T-cell-receptor-positive lymphocytes in sarcoidosis. Respiration. 1995;62:84–88
  353. Shiina T, Tamiya G, Oka A, et al.  Genome sequencing analysis of the 1.8 Mb entire human MHC class I region. Immunol Rev. 1999;167:193–199
  354. Shimizu K. Haradas, Behçet's, Vogt–Koyanagi syndromes—are they clinical entities?. Trans Am Acad Ophthalmol Otolaryngol. 1973;77:281–290
  355. Shindo Y, Ohno S, Usui M, et al.  Immunogenetic study of sympathetic ophthalmia. Tissue Antigens. 1997;49:111–115
  356. Siltzbach LE, James DG, Neville E, et al.  Course and prognosis of sarcoidosis around the world. Am J Med. 1974;57:847–852
  357. Silverstein BE, Wong IG. Reduction of cyclosporine dosage with ketoconazole in a patient with birdshot retinochoroidopathy. Am J Ophthalmol. 1998;125:106–108
  358. Singh VK, Biswas S, Anand R, Agarwal SS. Experimental autoimmune uveitis as animal model for human posterior uveitis. Indian J Med Res. 1998;107:53–67
  359. Singh VK, Mehrotra S, Agarwal SS. The paradigm of Th1 and Th2 cytokines (its relevance to autoimmunity and allergy). Immunol Res. 1999;20:147–161
  360. Smith MJ, Turton CW, Mitchell DN, et al.  Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax. 1981;36:296–298
  361. Smith RE, Godfrey WA, Kimura SJ. Complications of chronic cyclitis. Am J Ophthalmol. 1976;82:277–282
  362. Smith RE, Godfrey WA, Kimura SJ. Chronic cyclitis. I. Course and visual prognosis. Trans Am Acad Ophthalmol Otolaryngol. 1973;77:OP760–OP768
  363. Snyder DA, Tessler HH. Vogt–Koyanagi–Harada syndrome. Am J Ophthalmol. 1980;90:69–75
  364. Sonoda S, Nakao K, Ohba N. Extensive chorioretinal atrophy in Vogt–Koyanagi–Harada disease. Jpn J Ophthalmol. 1999;43:113–119
  365. Sorensen JA, Yannuzzi LA. Multiple evenescent white dot sydrome. In:  Albert D,  Jakobiec F editor. Principles & practice of ophthalmology. Philadelphia: WB Saunders and Co; 1996;, 913–8
  366. Sotozono C, Sano Y, Suzuki T, et al.  Soluble Fas ligand expression in the ocular fluids of uveitis patients. Curr Eye Res. 2000;20:54–57
  367. Spaide RF, Skerry JE, Yannuzzi LA, DeRosa JT. Lack of the HLA-DR2 specificity in multifocal choroiditis and panuveitis. Br J Ophthalmol. 1990;74:536–537
  368. Spaide RF, Sugin S, Yannuzzi LA, DeRosa JT. Epstein–Barr virus antibodies in multifocal choroiditis and panuveitis. Am J Ophthalmol. 1991;112:410–413
  369. Spalton DJ, Sanders MD. Fundus changes in histologically confirmed sarcoidosis. Br J Ophthalmol. 1981;65:348–358
  370. Specht CS, Mitchell KT, Bauman AE, Gupta M. Ocular histoplasmosis with retinitis in a patient with acquired immune deficiency syndrome. Ophthalmology. 1991;98:1356–1359
  371. Stanbury RM, Graham EM, Murray PI. Sarcoidosis. Int Ophthalmol Clin. 1995;35:123–137
  372. Streilein JW. Regional immunity and ocular immune privilege. Chem Immunol. 1999;73:11–38
  373. Streilein JW. General principles of immuno-ophthalmology. Dev Ophthalmol. 1999;30:1–23
  374. Streilein JW. Immunoregulatory mechanisms of the eye. Prog Retin Eye Res. 1999;18:357–370
  375. Sugi-Ikai N, Nakazawa M, Nakamura S, et al.  Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease. Invest Ophthalmol Vis Sci. 1998;39:996–1004
  376. Sugita S, Sagawa K, Mochizuki M, et al.  Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt–Koyanagi–Harada disease. Int Immunol. 1996;8:799–803
  377. Sugiura S. Vogt–Koyanagi–Harada disease. Jpn J Ophthalmol. 1978;22:9–35
  378. Suh DW, Pulido JS, Jampol LM, et al.  Coats-like response in pars planitis. Retina. 1999;19:79–80
  379. Sunakawa M, Okinami S. Epstein–Barr virus-related antibody pattern in uveitis. Jpn J Ophthalmol. 1985;29:423–428
  380. Suttorp-Schulten MS, Luyendijk L, van Dam AP, et al.  Birdshot chorioretinopathy and Lyme borreliosis. Am J Ophthalmol. 1993;115:149–153
  381. Suzuki Y, Hoshi K, Matsuda T, Mizushima Y. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease. J Rheumatol. 1992;19:588–592
  382. Svitra PP, Perry H: Vogt–Koyogani–Harada syndrome, in Albert D, Jakobiec F (eds): Principles & practice of ophthalmology. Philadelphia: WB Saunders and Co, 1996, pp 481–7
  383. Tabary T, Prochnicka-Chalufour A, Cornillet P, et al: [HLA-A29 sub-types and Birdshot choroido-retinopathy susceptibility: a possible resistance motif in the HLA-A29.1 molecule]. C R Acad Sci III 313:599–605, 1991
  384. Tagawa Y, Sugiura S: [Antibody-dependent cell-mediated cytotoxicity (ADCC) against melanocyte antigens in Vogt–Koyanagi–Harada disease (authors transl)]. Nippon Ganka Gakkai Zasshi 81:1101–4, 1977
  385. Takeno M, Kariyone A, Yamashita N, et al.  Excessive function of peripheral blood neutrophils from patients with Behçet's disease and from HLA-B51 transgenic mice. Arthritis Rheum. 1995;38:426–433
  386. Tanaka T, Suzuki J, Yamakawa N, Usui M. Molecular biological analysis of retinal and streptococcal heat-shock Protein 60. Jpn J Ophthalmol. 2000;44:692
  387. Tanaka T, Yamakawa N, Koike N, et al.  Behçet's disease and antibody titers to various heat-shock protein 60s. Ocul Immunol Inflamm. 1999;7:69–74
  388. Tanaka T, Yamakawa N, Yamaguchi H, et al.  Common antigenicity between Yersinia enterocolitica-derived heat-shock protein and the retina, and its role in uveitis. Ophthalmic Res. 1996;28:284–288
  389. Tang WM, Pulido JS, Eckels DD, et al.  The association of HLA-DR15 and intermediate uveitis. Am J Ophthalmol. 1997;123:70–75
  390. Tejada P, Sanz A, Criado D. Pars planitis in a family. Int Ophthalmol. 1994;18:111–113
  391. Thies O. Gedanken uber den ausbruch der sympathetischem ophthalmie. Klin Monatsbl Augenheilkd. 1947;112:185–187
  392. Tiedeman JS. Epstein–Barr viral antibodies in multifocal choroiditis and panuveitis. Am J Ophthalmol. 1987;103:659–663
  393. To KW, Jakobiec FA, Zimmerman LE: Sympathetic ophthalmia, in Albert D, Jakobiec F (eds): Principles & practice of ophthalmology. Philadelphia: WB Saunders and Co, 1996, pp 496–502
  394. Towler HM, Lightman S. Sympathetic ophthalmia. Int Ophthalmol Clin. 1995;35:31–42
  395. Towler HMA, Lightman S. Visual prognosis in Behçet's disease. Ocular Immunol Inflamm. 1993;1:249–254
  396. Tugal-Tutkun I, Urgancioglu M, Foster CS. Immunopathologic study of the conjunctiva in patients with Behçet disease. Ophthalmology. 1995;102:1660–1668
  397. Uchio E, Matsumoto T, Tanaka SI, Ohno S. Soluble intercellular adhesion molecule-1 (ICAM-1), CD4, CD8 and interleukin-2 receptor in patients with Behçet's disease and Vogt– Koyanagi–Haradas disease. Clin Exp Rheumatol. 1999;17:179–184
  398. Utsumi K, Kawanishi K, Kuriyama Y, et al: [Gamma delta T cells in peripheral blood and in bronchoalveolar lavage fluid from patients with sarcoidosis and idiopathic pulmonary fibrosis]. Nihon Kyobu Shikkan Gakkai Zasshi 33:1186–90, 1995
  399. Uusitalo M, Mikkila H, Karma A, Kivela T. Search for autoantibodies against the HNK-1 carbohydrate epitope in the human eye in intermediate uveitis. Acta Ophthalmol Scand. 2000;78:536–538
  400. Valesini G, Pivetti-Pezzi P, Mastrandrea F, et al.  Evaluation of T cell subsets in Behçet's syndrome using anti-T cell monoclonal antibodies. Clin Exp Immunol. 1985;60:55–60
  401. Van Metre TE. Role of the allergist in diagnosis and management of patients with uveitis. JAMA. 1966;195:167–172
  402. Vanderlugt CJ, Miller SD. Epitope spreading. Curr Opin Immunol. 1996;8:831–836
  403. Verity DH, Vaughan RW, Kondeatis E, et al.  Intercellular adhesion molecule-1 gene polymorphisms in Behçet's disease. Eur J Immunogenet. 2000;27:73–76
  404. Verity DH, Vaughan RW, Madanat W, et al.  Factor V Leiden mutation is associated with ocular involvement in Behçet disease. Am J Ophthalmol. 1999;128:352–356
  405. Verity DH, Wallace GR, Seed PT, et al.  Soluble adhesion molecules in Behçet's disease. Ocul Immunol Inflamm. 1998;6:81–92
  406. Verity DH, Wallace GR, Vaughan RW, et al.  HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. Tissue Antigens. 1999;54:264–272
  407. Wacker WB, Lipton MM. Experimental allergic uveitis. I. Production in the guinea pig and rabbit by immunization with retina in adjuvant. J Immunol. 1968;101:151–156
  408. Wacker WB, Lipton MM. Experimental allergic uveitis (homologous retina as uveitogenic antigen). Nature. 1965;206:253–254
  409. Wallace GR, Verity DH, Delamaine LJ, et al.  MIC-A allele profiles and HLA class I associations in Behçet's disease. Immunogenetics. 1999;49:613–617
  410. Watzke RC, Klein ML, Wener MH. Histoplasmosis-like choroiditis in a nonendemic area (the northwest United States). Retina. 1998;18:204–212
  411. Watzke RC, Packer AJ, Folk JC, et al.  Punctate inner choroidopathy. Am J Ophthalmol. 1984;98:572–584
  412. Weiter JJ, Roh S: Presumed ocular histoplasmosis syndrome, in Albert F, Jakobiec (eds): Principles & practice of ophthalmology. Philadelphia: WB Saunders and Co, 1996, pp 488–94
  413. Wetzig RP, Chan CC, Nussenblatt RB, et al.  Clinical and immunopathological studies of pars planitis in a family. Br J Ophthalmol. 1988;72:5–10
  414. Whitcup SM, Nussenblatt RB. Immunologic mechanisms of uveitis. New targets for immunomodulation. Arch Ophthalmol. 1997;115:520–525
  415. Williams BD, Lehner T. Immune complexes in Behçet's syndrome and recurrent oral ulceration. Br Med J. 1977;1:1387–1389
  416. Wilsher ML, Hallowes M, Birchall NM. Gamma/delta cells in tissue from patients with sarcoidosis. Thorax. 1996;51:1123–1126
  417. Winter FC, Yukins RE. The ocular pathology of Behçet's disease. Am J Ophthalmol. 1966;62:257–262
  418. Witmer R, Korner G: [Uveitis in childhood]. Ophthalmologica 152:277–82, 1966
  419. Wolf MD, Folk JC, Nelson JA, Peeples ME. Acute, posterior, multifocal, placoid, pigment epitheliopathy and Lyme disease. Arch Ophthalmol. 1992;110:750
  420. Wolf MD, Folk JC, Panknen CA, Goeken NE. HLA-B7 and HLA-DR2 antigens and acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol. 1990;108:698–700
  421. Wong VG, Anderson R, OBrien PJ. Sympathetic ophthalmia and lymphocyte transformation. Am J Ophthalmol. 1971;72:960–966
  422. Woodrow JC, Graham DR, Evans CC. Behçet's syndrome in HLA-identical siblings. Br J Rheumatol. 1990;29:225–227
  423. Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity (viral peptides activate human T cell clones specific for myelin basic protein). Cell. 1995;80:695–705
  424. Yabuki K, Inoko H, Ohno S. Immunogenetics and uveitis. Dev Ophthalmol. 1999;31:77–91
  425. Yabuki K, Mizuki N, Ota M, et al.  Association of MICA gene and HLA-B*5101 with Behçet's disease in Greece. Invest Ophthalmol Vis Sci. 1999;40:1921–1926
  426. Yamamoto JH, Fujino Y, Lin C, et al.  S-antigen specific T cell clones from a patient with Behçet's disease. Br J Ophthalmol. 1994;78:927–932
  427. Yamamoto JH, Minami M, Inaba G, et al.  Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease. Br J Ophthalmol. 1993;77:584–589
  428. Yamana S, Jones L, Aoi K, et al: [Lymphocyte subsets in erythema nodosum-like skin lesions from patients with Behçet's disease]. Ryumachi 25:344–7, 1985
  429. Yamashita N. Hyperreactivity of neutrophils and abnormal T cell homeostasis (a new insight for pathogenesis of Behçet's disease). Int Rev Immunol. 1997;14:11–19
  430. Yamashita N, Kaneoka H, Kaneko S, et al.  Role of gammadelta T lymphocytes in the development of Behçet's disease. Clin Exp Immunol. 1997;107:241–247
  431. Yato H, Matsumoto Y. CD56+ T cells in the peripheral blood of uveitis patients. Br J Ophthalmol. 1999;83:1386–1388
  432. Yazici H, Ozyazgan Y. Medical management of Behçet's syndrome. Dev Ophthalmol. 1999;31:118–131
  433. Yokota K, Hayashi S, Fujii N, et al.  Antibody response to oral streptococci in Behçet's disease. Microbiol Immunol. 1992;36:815–822
  434. Yokoyama MM, Matsui Y, Yamashiroya HM, et al.  Humoral and cellular immunity studies in patients with Vogt–Koyanagi-Harada syndrome and pars planitis. Invest Ophthalmol Vis Sci. 1981;20:364–370
  435. Yoshikawa K, Kotake S, Matsuda H: [Behçet's disease and streptococcal antigens]. Nippon Ganka Gakkai Zasshi 100:173–80, 1996
  436. Young NJ, Bird AC, Sehmi K. Pigment epithelial diseases with abnormal choroidal perfusion. Am J Ophthalmol. 1980;90:607–618
  437. Young RC, Hackney RL, Harden KA. Epidemiology of sarcoidosis (ethnic and geographic considerations). J Natl Med Assoc. 1974;66:386–388
  438. Zaharia MA, Lamarche J, Laurin M. Sympathetic uveitis 66 years after injury. Can J Ophthalmol. 1984;19:240–243
  439. Zhao M, Jiang Y, Abrahams IW. Association of HLA antigens with Vogt–Koyanagi–Harada syndrome in a Han Chinese population. Arch Ophthalmol. 1991;109:368–370
  440. Zwirner NW, Dole K, Stastny P. Differential surface expression of MICA by endothelial cells, fibroblasts, keratinocytes, and monocytes. Hum Immunol. 1999;60:323–330
  441. Zwirner NW, Fernandez-Vina MA, Stastny P. MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics. 1998;47:139–148

☆ The authors have no commercial or proprietary interest in any concept or product discussed in this article

PII: S0039-6257(01)00275-2

Survey of Ophthalmology
Volume 46, Issue 3 , Pages 209-233 , November 2001

Article Tools

* Image Usage & Resolution